|
WO1998036738A1
(en)
*
|
1997-02-20 |
1998-08-27 |
Therics, Inc. |
Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same
|
|
DE69934505T2
(de)
*
|
1998-05-18 |
2007-10-04 |
Takeda Pharmaceutical Co. Ltd. |
Im munde zerfallende tablette enthaltend ein benzimidazole
|
|
US6284270B1
(en)
*
|
1999-08-04 |
2001-09-04 |
Drugtech Corporation |
Means for creating a mass having structural integrity
|
|
AU2001273687A1
(en)
*
|
2000-07-10 |
2002-01-21 |
Massachusetts Institute Of Technology |
Method and materials for controlling migration of binder liquid in a powder
|
|
US7014867B2
(en)
*
|
2001-06-28 |
2006-03-21 |
Ucb Farchim Sa |
Tablet comprising cetirizine and pseudoephedrine
|
|
JP4426286B2
(ja)
*
|
2001-07-10 |
2010-03-03 |
テバ ファーマシューティカル インダストリーズ リミティド |
０次、０次−二相性、上昇型又は下降型薬物放出のための薬物送達システム
|
|
EP1439824A2
(en)
*
|
2001-10-29 |
2004-07-28 |
Therics, Inc. |
Three-dimensional suspension printing of dosage forms
|
|
CA2464478C
(en)
*
|
2001-10-29 |
2012-03-20 |
Therics, Inc. |
A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form
|
|
DE60323482D1
(de)
|
2002-05-06 |
2008-10-23 |
Massachusetts Inst Technology |
Diffusionskontrollierte arzneiform sowie herstellungsmethode mittels dreidimensionalem drucken
|
|
WO2004047793A1
(en)
*
|
2002-11-26 |
2004-06-10 |
Alk-Abelló A/S |
Pharmaceutical allergen product
|
|
EP1804804B1
(en)
|
2004-09-21 |
2012-01-25 |
Hypnion, Inc. |
3-[4-(DIBENZO[b,f][1,4]OXAZEPIN-11-YL)-PIPERAZIN-1-YL]-2,2-DIMETHYL PROPANOIC ACID FOR USE IN THE TREATMENT OF SLEEP DISORDERS
|
|
US7829000B2
(en)
*
|
2005-02-25 |
2010-11-09 |
Hewlett-Packard Development Company, L.P. |
Core-shell solid freeform fabrication
|
|
US8187659B2
(en)
|
2006-05-02 |
2012-05-29 |
Jerry Robertson Real Estate Llc |
Solid medicament dosage form consumption aid
|
|
ES2500165T3
(es)
|
2006-06-29 |
2014-09-30 |
Kinex Pharmaceuticals, Llc |
Composiciones de biarilo y métodos para modular una cascada de quinasas
|
|
EP2217229B1
(en)
|
2007-10-20 |
2020-10-14 |
Athenex, Inc. |
Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
|
|
DK2493457T3
(en)
|
2009-10-30 |
2017-10-02 |
Ix Biopharma Ltd |
QUICK-SOLVING SOLID DOSAGE FORM
|
|
US12186426B2
(en)
|
2009-10-30 |
2025-01-07 |
Ix Biopharma Ltd. |
Solid dosage form
|
|
AU2011233663B2
(en)
*
|
2010-04-03 |
2016-04-14 |
Praful Doshi |
Medical devices including medicaments and methods of making and using same
|
|
EP2632920A1
(en)
|
2010-10-27 |
2013-09-04 |
Dynamix Pharmaceuticals Ltd. |
Sulfonamides for the modulation of pkm2
|
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
|
US8722636B2
(en)
|
2011-01-31 |
2014-05-13 |
New Market Pharmaceuticals, LLC |
Animal treatments
|
|
EP2684167B1
(en)
|
2011-03-08 |
2020-09-09 |
Eutropics Pharmaceuticals, Inc. |
Compositions and methods useful for treating diseases
|
|
ITMI20110791A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri in grado di metabolizzare gli ossalati.
|
|
ITMI20110792A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
|
|
ITMI20110793A1
(it)
|
2011-05-09 |
2012-11-10 |
Probiotical Spa |
Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
|
|
WO2012160447A1
(en)
|
2011-05-25 |
2012-11-29 |
Dynamix Pharmaceuticals Ltd. |
3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases
|
|
JP6054379B2
(ja)
|
2011-06-07 |
2016-12-27 |
クレベクセル・ファーマＣｌｅｖｅｘｅｌ Ｐｈａｒｍａ |
キナーゼをモジュレートするための組成物および方法
|
|
ITMI20111718A1
(it)
|
2011-09-23 |
2013-03-24 |
Probiotical Spa |
Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
|
|
US9245061B2
(en)
*
|
2012-04-25 |
2016-01-26 |
Shapeways, Inc. |
Weight-based identification of three dimensional printed parts
|
|
ES3034104T3
(en)
|
2012-05-02 |
2025-08-13 |
Newmarket Pharmaceuticals Llc |
Pharmaceutical compositions for direct systemic introduction
|
|
WO2013192423A2
(en)
|
2012-06-20 |
2013-12-27 |
Eutropics Pharmaceuticals, Inc. |
Methods and compositions useful for treating diseases involving bcl-2 family proteins with quinoline derivatives
|
|
CA2883144C
(en)
|
2012-08-30 |
2023-01-17 |
Kinex Pharmaceuticals, Llc |
N-(3-fluorobenzyl)-2-(5-(4-morpholinophenyl)pyridin-2-yl) acetamide as protein|tyrosine kinase modulators
|
|
US9545376B2
(en)
|
2013-01-23 |
2017-01-17 |
Arx, Llc |
Production of unit dose constructs
|
|
JP6466399B2
(ja)
|
2013-03-15 |
2019-02-06 |
アプレシア・ファーマスーティカルズ・カンパニー |
トピラマートの急速分散性の剤形
|
|
CA2906107C
(en)
*
|
2013-03-15 |
2021-08-24 |
Aprecia Pharmaceuticals Company |
Rapidly dispersible dosage form of oxcarbazepine
|
|
CA2906029C
(en)
*
|
2013-03-15 |
2017-09-05 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
|
US9339489B2
(en)
|
2013-03-15 |
2016-05-17 |
Aprecia Pharmaceuticals Company |
Rapid disperse dosage form containing levetiracetam
|
|
WO2014176389A1
(en)
|
2013-04-24 |
2014-10-30 |
Temple University - Of The Commonwealth System Of Higher Education |
Solid dosage form containing arabinogalactan
|
|
ITMI20130793A1
(it)
|
2013-05-14 |
2014-11-15 |
Probiotical Spa |
Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
|
|
EP3033188A4
(en)
|
2013-08-16 |
2017-03-22 |
The Exone Company |
Three-dimensional printed metal-casting molds and methods for making the same
|
|
US20160243621A1
(en)
|
2013-10-17 |
2016-08-25 |
The Exone Company |
Three-Dimensional Printed Hot Isostatic Pressing Containers and Processes for Making Same
|
|
US20160332373A1
(en)
|
2013-12-23 |
2016-11-17 |
The Exone Company |
Methods and Systems for Three-Dimensional Printing Utilizing Multiple Binder Fluids
|
|
US11001048B2
(en)
|
2013-12-23 |
2021-05-11 |
The Exone Company |
Method of three-dimensional printing using a multi-component build powder
|
|
EP3086921B1
(en)
*
|
2013-12-23 |
2019-07-31 |
The Exone Company |
Methods and systems for three-dimensional printing utilizing a jetted-particle binder fluid
|
|
EP3137113A4
(en)
*
|
2014-04-30 |
2017-03-22 |
Blaesi, Aron H. |
Melt-processed polymeric cellular dosage form
|
|
EP3148730A1
(en)
|
2014-05-29 |
2017-04-05 |
The Exone Company |
Process for making nickel-based superalloy articles by three-dimensional printing
|
|
EP3169499A2
(en)
|
2014-07-17 |
2017-05-24 |
The Exone Company |
Methods and apparatuses for curing three-dimensional printed articles
|
|
WO2016081472A1
(en)
|
2014-11-21 |
2016-05-26 |
Biohaven Pharmaceutical Holding Company Ltd. |
Sublingual formulation of riluzole
|
|
EP3227109B1
(en)
|
2014-12-03 |
2020-08-19 |
The Exone Company |
Process for making densified carbon articles by three dimensional printing
|
|
AU2016272089B2
(en)
|
2015-06-03 |
2021-02-18 |
Triastek, Inc. |
Dosage forms and use thereof
|
|
EP3108874A1
(en)
*
|
2015-06-26 |
2016-12-28 |
TRB Chemedica AG |
Ophthalmologic pharmaceutical composition
|
|
US11129798B2
(en)
*
|
2016-08-19 |
2021-09-28 |
Aron H. Blaesi |
Fibrous dosage form
|
|
EP3368010B1
(en)
*
|
2015-10-26 |
2025-12-10 |
Blaesi, Aron H. |
Solid dosage form immediate drug release and apparatus and method for manufacture thereof
|
|
EP3429564A1
(en)
*
|
2016-03-18 |
2019-01-23 |
Grünenthal GmbH |
Combination of drugs having different potency
|
|
ITUA20162013A1
(it)
|
2016-03-24 |
2017-09-24 |
Probiotical Spa |
Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
|
|
EP3441065B1
(en)
*
|
2016-04-06 |
2024-10-09 |
Astellas Pharma Inc. |
Fast-eluting three-dimensional molding, filament for fast-eluting three-dimensional molding, and material for fast-eluting three-dimensional molding
|
|
AU2017261372B2
(en)
|
2016-05-05 |
2019-02-14 |
Triastek, Inc. |
Controlled release dosage form
|
|
LT3458053T
(lt)
|
2016-05-20 |
2022-02-25 |
Biohaven Pharmaceutical Holding Company Ltd. |
Riluzolo, rilizolo provaistų arba riluzolo analogų panaudojimas kartu su imunoterapijomis vėžio formų gydymui
|
|
TWI755418B
(zh)
|
2016-08-12 |
2022-02-21 |
美商亞瑟尼克斯公司 |
聯芳組成物和調控激酶級聯之方法
|
|
US11040491B2
(en)
|
2016-10-19 |
2021-06-22 |
Shapeways, Inc. |
Systems and methods for identifying three-dimensional printed objects
|
|
IL267689B2
(en)
|
2016-12-31 |
2025-05-01 |
Bioxcel Therapeutics Inc |
Use of sublingual dexmedetomidine for the treatment of agitation
|
|
EP3573602A4
(en)
|
2017-01-26 |
2020-09-16 |
Triastek, Inc. |
DOSAGE FORMS OF CONTROLLED RELEASE AT SPECIFIC GASTROINTESTINAL SITES
|
|
US11602502B2
(en)
|
2017-02-24 |
2023-03-14 |
Hewlett-Packard Development Company, L.P. |
Three-dimensional (3D) printing a pharmaceutical tablet
|
|
EA201992116A1
(ru)
|
2017-03-08 |
2020-01-29 |
СИНРКС ФАРМА, ЭлЭлСи |
Фармацевтические составы флороглюцинола и триметилфлороглюцинола
|
|
JP7358340B2
(ja)
|
2017-05-26 |
2023-10-10 |
インフィニット・マテリアル・ソリューションズ，エルエルシー |
水溶性ポリマー組成物
|
|
EP4483956B1
(en)
|
2017-11-12 |
2025-12-31 |
Biohaven Therapeutics Ltd. |
TRORILUZOLE INTENDED FOR USE IN THE TREATMENT OF SPINOCEREBELLOUS ATAXIA 3 (SCA3)
|
|
CN108066302B
(zh)
*
|
2017-12-28 |
2020-09-11 |
无限极（中国）有限公司 |
一种快速分散固体制剂的制备方法及制备的快速分散固体制剂
|
|
CN116270513A
(zh)
|
2018-01-09 |
2023-06-23 |
南京三迭纪医药科技有限公司 |
一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
|
|
US10350822B1
(en)
|
2018-01-09 |
2019-07-16 |
Triastek Inc. |
Dosage forms with desired release profiles and methods of designing and making thereof
|
|
DE102018107585B3
(de)
*
|
2018-03-29 |
2019-03-28 |
Universität Rostock |
Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen
|
|
BR112020026672A2
(pt)
|
2018-06-27 |
2021-03-30 |
Bioxcel Therapeutics, Inc. |
Formulações de filme contendo dexmedetomidina e métodos para produzi-las
|
|
JP7614103B2
(ja)
|
2018-10-15 |
2025-01-15 |
アプレシア・ファーマスーティカルズ・エルエルシー |
包装内に剤形を形成する方法およびシステム
|
|
EP3883546A1
(en)
|
2018-11-21 |
2021-09-29 |
Rosemont Pharmaceuticals Ltd |
Oral topiramate suspension formulations with extended shelf stability and enhanced bioavailability
|
|
US12103229B2
(en)
*
|
2019-03-15 |
2024-10-01 |
Ricoh Company, Ltd. |
Jettable temporary binders to create removable support materials
|
|
JP7287032B2
(ja)
|
2019-03-20 |
2023-06-06 |
株式会社リコー |
シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法
|
|
AU2020277668A1
(en)
*
|
2019-05-21 |
2021-11-25 |
Dfe Pharma Gmbh & Co. Kg |
Lactose powder bed three dimensional printing
|
|
BR112022000992A2
(pt)
|
2019-07-19 |
2022-06-14 |
Arx Llc |
Regimes de tratamento de dexmedetomidina não sedantes
|
|
EP3789015A1
(en)
*
|
2019-09-05 |
2021-03-10 |
Universität Innsbruck |
Fast consolidating compounds
|
|
TWI734309B
(zh)
*
|
2019-12-19 |
2021-07-21 |
水星生醫股份有限公司 |
滲透性噴塗製作藥錠裝置
|
|
US12371581B2
(en)
|
2020-03-25 |
2025-07-29 |
Infinite Material Solutions, Llc |
High performance water soluble polymer compositions
|
|
JP2023533478A
(ja)
|
2020-06-26 |
2023-08-03 |
アプレシア・ファーマスーティカルズ・エルエルシー |
内部空洞を有する迅速口内分散可能な錠剤
|
|
EP4238556A4
(en)
|
2020-10-30 |
2024-09-25 |
Triastek, Inc. |
GASTRORETENTIVE PHARMACEUTICAL DOSAGE FORM
|
|
EP4277624B1
(en)
|
2021-01-18 |
2026-01-14 |
Biohaven Therapeutics Ltd. |
Troriluzole for use in the treatment of alzheimer's disease of mild severity
|
|
WO2024108082A1
(en)
|
2022-11-18 |
2024-05-23 |
Aprecia Pharmaceuticals LLC |
Orodispersive dosage forms containing droxidopa
|
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|